MagNA Pure 96 System

MagNA Pure 96 System including instrument, kits, and accessories are for in vitro diagnostic use unless otherwise noted.

magna pure 96
Effortless purification, confidence from automation

The MagNA Pure 96 System purifies DNA, RNA, and viral nucleic acids from a wide range of starting materials using magnetic glass particle technology.

Preprogrammed software protocols are tailored to a diversity of sample requirements. Resulting nucleic acids are suitable for a broad range of downstream applications.

The MagNA Pure 96 System effortlessly processes up to 96 samples in less than one hour using barcoded, prefilled trays with ready-to-use reagents.

Experience seamless data management using intuitive features, such as the link to a laboratory information management system (LIMS).

Features

Benefits

Speed and throughput

  • Approximately 1 hour for processing a 96 sample run
  • Multiple sample types can be processed in one run

Quick time-to-result for clinicians and patients

Convenience
  • Only two kits needed to cover various diagnostic applications
  • Few reagents and consumables needed
  • Connectivity (LIMS and bidirectional file sharing)

Minimized error risk
Low training effort & hands-on time

Robustness

  • Insusceptible against tested substance interferences
  • Very stable against cross contamination

Confidence & trust in your results

Performance
  • Broad range of sample materials
  • Excellent precision, purification efficiency and linear range
  • Minimal lot-to-lot variation

One solution for various needs

Service and support

  • Globally, approximately 3,500 employees at Roche Diagnostics are dedicated to service and support
  • Roche is a leading supplier of IVD products. No other company has more experience in molecular diagnostics

Minimum downtime
Cost effectiveness

Software

The Magna Pure 96 system is on software version 3.1 currently.

If you need assistance to update your software system, please contact your local Roche representative.

Specifications

  • Number of samples

    1 to 96 reactions per run

  • Sample volume

    50 to 500 µL with 96 reactions per run
    1000 µL with 48 reactions per run

  • Maximum number of sample types within one run:

    10 (whole blood, plasma, serum, urine, swabs, stool, sputum, BAL, CSF, bacterial cultures)

  • Run time for 96 reactions:

    Approx. 50-60 minutes for 200 µL sample volumes
    Approx. 80-90 minutes for 500 µL sample volumes

  • Reagent type:

    Prefilled, ready-to-use

  • LIMS connectivity

    Yes

  • 21CFR part 11 (subsection B) compatibility

    Yes

  • IVD compliance

    Instrument complies with the requirements of IVD directive 98/79/EC

The MagNA Pure 96 System is a high-throughput instrument for automated nucleic acid purification. Typical run duration is less than one hour for 96 standard volume samples. Applications are very flexible, due to a diversity of software purification protocols using barcoded, prefilled trays with ready-to-use reagents.

MagNA Pure 96 kits are designed profiting from our more than ten year expertise in magnetic glass particle technology. We have streamlined the purification process to a very small number of reagents, consumables and steps.

Optimized preprogrammed purification protocols ensure routine sample handling and high quality, reproducible nucleic acid yields. Choose the appropriate purification protocol for your sample material and target nudeic acid:

Form Successfully Submitted!
Thank you for your submission!
text
Target Protocol name Input sample type and sample volumes
The latest version of MagNA Pure 96 protocols are available to download from the table below (not available in US)
Elution volume Run time*** (h:mm)
Whole blood Plasma (citrate) Plasma (EDTA) Serum Swabs BAL*
Sputum CSF Urine Stool Cultured cells Fresh-frozen tissue FFPET**
Bacterial, fungal and viral NA Pathogen Universal 200 1 200 μL 50, 100 μL 1:00
Viral NA Plasma SV 1 50, 100, 200 μL 1:00
Viral NA Plasma ext lys SV 1

Protocol optimized with external lysis reagent

350, 450 μL lysate from 100, 200 μL sample 1:00
Viral NA Universal SV 1 50, 100, 200 μL 50, 100, 200 μL 1:00
Pathogen Universal 500 2 500 μL 1:30
Pathogen Universal 1000 2 1000 μL 1:40
Viral NA Plasma LV 2 500 μL 1:10
Viral NA Plasma LV 1000 2 1000 μL 1:20
Viral NA Plasma ext lys LV 2

Protocol optimized with external lysis reagent

1000 μL lysate from 500 μL sample 1:10
Viral NA Universal LV 2 500 μL 500 μL 1:30
Viral NA Universal LV 1000 2 1000 μL 1000 μL 1:30
Genomic DNA DNA Blood SV 1

Recommended for elution of predominantly double-stranded DNA

50, 100 or 200 μL ≤ 2x106 cells/samples 50, 100 μL 1:00
DNA Blood ext lys SV 1

Protocol optimized with external lysis reagent

300, 350, or 450 μL lysate from
50, 100, 200 μL sample
0:50
DNA Cells SV 1 Up to 5x105 cultured cells in 200 μL PBS 100 μL 1:00
DNA Tissues SV 1 Up to 5 mg in 200 μL 100, 200 μL 1:20
DNA FFPE SV 1 200 μL lysate from 2x5 μL sections 50, 100 μL 1:00
DNA Blood LV 2 500 μL (≤ 1x107 cells/ml) 100, 200 μL 1:20
DNA Blood LV 1000 2 1000 μL (≤ 1x107 cells/ml) 1:30
DNA Blood ext lys LV 2

Protocol optimized with external lysis reagent

1000 μL lysate from 500 μL sample (≤ 1x107 cells/ml) 100, 200 μL 0:50
DNA Cells LV 1 Up to 1x106 cultured cells in 200 μL PBS 100, 200 μL 1:20
DNA Tissue LV 2 Up to 25 mg in 200 μL 200 μL 1:20
Cell-free NA cfNA ss 2000 2

Protocol optimized for single-stranded DNA

2000 μL 50, 100 μL 2:00
cfNA ss 4000 2

Protocol optimized for single-stranded DNA

4000 μL 2:20
cfNA ds 2000 2

Protocol optimized for single-stranded DNA

2000 μL 100, 200 μL 2:20
cfNA ds 4000 2

Protocol optimized for single-stranded DNA

4000 μL 2:50
Total RNA Cellular RNA LV 3 Up to 1x106 cultured cells in 200 μL PBS 50, 100, 200 μL 1:30
RNA Blood LV 400 3 900 μL stabilized whole blood from 400 μL whole blood 50, 100, 200 μL 1:30
RNA Blood LV 800 3 1800 μL stabilized whole blood from 800 μL whole blood 100, 200 μL 1:30
RNA PAXgene LV 3 PAXgene pellet in 400 μL PBS 100, 200 μL 1:30
RNA PAXgene Half Tube LV 3 Half PAXgene pellet in 200 μL PBS 50, 100 μL 1:30
RNA Tissue FF Standard LV 3 Up to 10 mg in 350 μL 50, 100, 200 μL 1:30
RNA Tissue FF High LV 3 Up to 25 mg in 700 μL 100, 200 μL 1:30
RNA Tissue FFPE LV 3 150 μL lysate from 2x5 μm sections 50, 100 μL 1:30
Liquid handling Sample Transfer
to the processing cartridge
50 µL to 1000 µL NA
Archive Plate Transfer
for archiving purposes
5 μL to 200 μL NA
PCR Setup with Mixing NA
PCR Setup without Mixing NA

1 MagNA Pure 96 DNA and Viral NA Small Volume Kit (cat. no. 06 543 588 001)
2 MagNA Pure 96 DNA and Viral NA Large Volume Kit (cat. No. 06 374 891 001)
3 MagNA Pure 96 Cellular RNA Large Volume Kit (cat no. 05 467 535 001)

To get better results, Roche provides various External Lysis Buffers: MagNA Pure cfNA Buffer Set (Cat. no. 07 794 398 001), MagNA Pure External Lysis Buffer (Cat. no. 06 374 913 001), MagNA Pure Bacterial Lysis Buffer (Cat. no. 06 374 921 001), MagNA Pure DNA Tissue Lysis Buffer (Cat. no. 06 640 702 001), MagNA Pure FFPET Buffer Set† (Cat. no. 08 447 144 001) and S.T.A.R. Buffer§ (Cat. no. 03 335 208 001). Please refer to the instructions for use manual for more details.

*BAL - Bronchoalveolar Lavage
**FFPET - formalin-fixed paraffin-embedded tissue
***These times are approximate and should only be used as a guidance.
For general laboratory use.
§For life science research only. Not for use in diagnostic procedures.